SOPHiA GENETICS S.A. (SOPH) Insider Trading

Over the last 3 months, SOPH insiders made 0 open-market buys and 76 sales, a net sale of -$1.1M (SEC Form 4). Over the last 6 months, 28 institutions increased and 15 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
76
Net (3m)
-$1.1M
Insider trades by month Buys Sells
Mar
Apr
May
Jun
Context3-month price +13.3%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jun 1, 2026Menu Philippeofficer: Chief Medical OfficerSell5,000$4.95
May 20, 2026Menu Philippeofficer: Chief Medical OfficerSell608$4.61
May 20, 2026Valente Manuelaofficer: Chief People OfficerSell380$4.60
May 20, 2026Puylaert Kevinofficer: Chief Sales OfficerSell33$4.54
May 20, 2026Camblong Jurgidirector, officer: Chief Executive OfficerSell4,486$4.60
May 20, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell608$4.60
May 20, 2026Muken Rossofficer: PresidentSell761$4.60
May 20, 2026Van Well Daanofficer: Chief Legal OfficerSell684$4.60
May 14, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell4,000$4.54
May 13, 2026HIBBS KATHY LdirectorSell7,508$4.67
May 13, 2026Menu Philippeofficer: Chief Medical OfficerSell5,000$4.67
May 12, 2026Camblong Jurgidirector, officer: Chief Executive OfficerSell8,500$5.09
Apr 28, 2026Menu Philippeofficer: Chief Medical OfficerSell5,000$4.82
Apr 21, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell608$5.21
Apr 21, 2026Van Well Daanofficer: Chief Legal OfficerSell684$5.20
Apr 21, 2026Camblong Jurgidirector, officer: Chief Executive OfficerSell4,486$5.21
Apr 21, 2026Menu Philippeofficer: Chief Medical OfficerSell608$5.20
Apr 21, 2026Muken Rossofficer: PresidentSell760$5.20
Apr 21, 2026Puylaert Kevinofficer: Chief Sales OfficerSell33$5.08
Apr 21, 2026Valente Manuelaofficer: Chief People OfficerSell380$5.20
Apr 16, 2026Camblong Jurgidirector, officer: Chief Executive OfficerSell17,473$5.00
Apr 16, 2026Menu Philippeofficer: Chief Medical OfficerSell1,600$4.96
Apr 16, 2026Muken Rossofficer: PresidentSell2,800$4.96
Apr 16, 2026Camblong Jurgidirector, officer: Chief Executive OfficerSell43,129$4.96
Apr 16, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell600$4.97
Apr 14, 2026Muken Rossofficer: PresidentSell3,687$4.69
Apr 14, 2026Menu Philippeofficer: Chief Medical OfficerSell3,400$4.76
Apr 14, 2026Van Well Daanofficer: Chief Legal OfficerSell2,400$4.67
Apr 14, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell3,706$4.68
Apr 14, 2026Xu Zhenyuofficer: Chief Scientific OfficerSell1,014$4.76

Source: SOPH SEC Form 4 filings, latest Jun 1, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their SOPH positions over the last 6 months (SEC Form 13F).

Increased
28
New positions
28
Reduced
15
Sold out
18
Largest moves
InstitutionActionSharesFiled
GENERATION INVESTMENT MANAGEMENT LLPUnchanged6.8MFeb 12, 2026
GENERATION INVESTMENT MANAGEMENT LLPUnchanged6.8MMay 14, 2026
AKRE CAPITAL MANAGEMENT LLCUnchanged3.7MMay 14, 2026
AKRE CAPITAL MANAGEMENT LLCUnchanged3.7MFeb 13, 2026
BANQUE PICTET & CIE SAUnchanged2.2MApr 14, 2026
BANQUE PICTET & CIE SAUnchanged2.2MJan 16, 2026
SOLEUS CAPITAL MANAGEMENT, L.P.New Position1.9MMay 14, 2026
ROYCE & ASSOCIATES LPIncreased1.8MMay 12, 2026
PRINCIPAL FINANCIAL GROUP INCIncreased1.4MMay 4, 2026
ALTA WEALTH ADVISORS LLCUnchanged1.4MFeb 3, 2026
ALTA WEALTH ADVISORS LLCUnchanged1.4MMay 5, 2026
PRINCIPAL FINANCIAL GROUP INCIncreased1.4MFeb 2, 2026
KENNEDY CAPITAL MANAGEMENT LLCNew Position928KMay 13, 2026
ESSEX INVESTMENT MANAGEMENT CO LLCNew Position693KMay 11, 2026
ENSIGN PEAK ADVISORS, INCIncreased445KMay 13, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.